Personalized Psychotherapy for Adult Depression: A Meta-Analytic Review

Behavior Therapy

Volumn 47, Issue 6, 2016, Pages 966-980

  Cuijpers, Pim ^a   Ebert, David D ^b   Acarturk, Ceren ^c   Andersson, Gerhard ^d   Cristea, Ioana A ^e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c ISTANBUL SEHIR UNIVERSITY   (Turkey)

^d LINKÖPING UNIVERSITY   (Sweden)

^e BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

cognitive behavioral therapy; depression; meta analysis; personalized medicine; psychotherapy

Indexed keywords

ADULT; CALCULATION; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EFFECT SIZE; HUMAN; META ANALYSIS; PERSONALIZED MEDICINE; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY STUDENT; CLIENT CENTERED THERAPY; COGNITIVE THERAPY; DEPRESSIVE DISORDER; PROCEDURES; PSYCHOTHERAPY;

COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; PERSON-CENTERED THERAPY; PRECISION MEDICINE; PSYCHOTHERAPY;

EID: 84977645655     PISSN: 00057894     EISSN: 18781888     Source Type: Journal    
DOI: 10.1016/j.beth.2016.04.007     Document Type: Article

References (52)

1. Andrews, G., Issakidis, C., Sanderson, K., Corry, J., Lapsley, H., Utilising survey data to inform public policy: Comparison of the cost-effectiveness of treatment of ten mental disorders. British Journal of Psychiatry 184 (2004), 526–533.
2. Barth, J., Munder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., Cuijpers, P., Comparative efficacy of seven psychotherapeutic interventions for patients with depression: A network meta-analysis. PLoS Medicine, 10(5), 2013, e1001454, 10.1371/journal.pmed.1001454.
3. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression. Archives of General Psychiatry 4 (1961), 561–571.
4. Borenstein, M., Hedges, L.V., Higgins, J.P.T., Rothstein, H.R., Introduction to meta-analysis. 2009, Wiley, Chichester, UK.
5. Brookes, S.T., Whitely, E., Egger, M., Smith, G.D., Mulheran, P.A., Peters, T.J., Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test. Journal of Clinical Epidemiology 57:3 (2004), 229–236, 10.1016/j.jclinepi.2003.08.009.
6. Brownell, K.D., Wadden, T.A., The heterogeneity of obesity: Fitting treatments to individuals. Behavior Therapy 22:2 (1991), 153–177, 10.1016/S0005-7894(05)80174-1.
7. Churchill, R., Hunot, V., Corney, R., Knapp, M., McGuire, H., Tylee, A., Wessely, S., A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technology Assessment 5:35 (2001), 1–173.
8. Cuijpers, P., Personalized treatment for functional outcome in depression. Medicographia, 36(4), 2014.
9. Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., Dobson, K.S., A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Canadian Journal of Psychiatry 58:7 (2013), 376–385.
10. Cuijpers, P., Geraedts, A.S., van Oppen, P., Andersson, G., Markowitz, J.C., van Straten, A., Interpersonal psychotherapy for depression: A meta-analysis. American Journal of Psychiatry 168:6 (2011), 581–592, 10.1176/appi.ajp.2010.10101411.
11. Cuijpers, P., Reynolds, C.F., Donker, T., Li, J., Andersson, G., Beekman, A., Personalized treatment of adult depression: Medication, psychotherapy, or both? A systematic review. Depression and Anxiety 29:10 (2012), 855–864, 10.1002/da.21985.
12. Cuijpers, P., Turner, E.H., Koole, S.L., van Dijke, A., Smit, F., What is the threshold for a clinically relevant effect? The case of major depressive disorders. Depression and Anxiety 31:5 (2014), 374–378, 10.1002/da.22249.
13. Cuijpers, P., van Straten, A., Andersson, G., van Oppen, P., Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies. Journal of Consulting and Clinical Psychology 76:6 (2008), 909–922, 10.1037/a0013075.
14. Cuijpers, P., van Straten, A., Bohlmeijer, E., Hollon, S.D., Andersson, G., The effects of psychotherapy for adult depression are overestimated: A meta-analysis of study quality and effect size. Psychological Medicine 40:2 (2010), 211–223, 10.1017/S0033291709006114.
15. Cuijpers, P., van Straten, A., Warmerdam, L., Problem solving therapies for depression: A meta-analysis. European Psychiatry 22:1 (2007), 9–15, 10.1016/j.eurpsy.2006.11.001.
16. Cuijpers, P., van Straten, A., Warmerdam, L., Andersson, G., Psychological treatment of depression: A meta-analytic database of randomized studies. BMC Psychiatry, 8, 2008, 36, 10.1186/1471-244X-8-36.
17. Cuijpers, P., van Straten, A., Warmerdam, L., Smits, N., Characteristics of effective psychological treatments of depression: A metaregression analysis. Psychotherapy Research 18:2 (2008), 225–236, 10.1080/10503300701442027.
18. DeRubeis, R.J., Cohen, Z.D., Forand, N.R., Fournier, J.C., Gelfand, L.A., Lorenzo-Luaces, L., The Personalized Advantage Index: Translating research on prediction into individualized treatment recommendations. A demonstration. PloS One, 9(1), 2014, e83875, 10.1371/journal.pone.0083875.
19. Driessen, E., Cuijpers, P., de Maat, S.C.M., Abbass, A.A., de Jonghe, F., Dekker, J.J.M., The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis. Clinical Psychology Review 30:1 (2010), 25–36, 10.1016/j.cpr.2009.08.010.
20. Ekers, D., Webster, L., Van Straten, A., Cuijpers, P., Richards, D., Gilbody, S., Behavioural activation for depression: An update of meta-analysis of effectiveness and sub group analysis. PloS One, 9(6), 2014, e100100, 10.1371/journal.pone.0100100.
21. Elkin, I., Gibbons, R.D., Shea, M.T., Sotsky, S.M., Watkins, J.T., Pilkonis, P.A., Hedeker, D., Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology 63:5 (1995), 841–847.
22. Fournier, J.C., DeRubeis, R.J., Hollon, S.D., Dimidjian, S., Amsterdam, J.D., Shelton, R.C., Fawcett, J., Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA 303:1 (2010), 47–53, 10.1001/jama.2009.1943.
23. Hamilton, M., A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23 (1960), 56–62.
24. Hedges, L.V., Olkin, I., Statistical methods for meta-analysis. 1985, Academic Press, Orlando, FL.
25. Higgins, J.P.T., Green, S., (eds.) Cochrane handbook for systematic reviews of interventions version 5.1.0, 2011, Cochrane Collaboration.
26. Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560, 10.1136/bmj.327.7414.557.
27. Hollon, S.D., Muñoz, R.F., Barlow, D.H., Beardslee, W.R., Bell, C.C., Bernal, G., Sommers, D., Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access. Biological Psychiatry 52:6 (2002), 610–630.
28. Ioannidis, J.P.A., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335:7626 (2007), 914–916, 10.1136/bmj.39343.408449.80.
29. Jain, F.A., Hunter, A.M., Brooks, J.O., Leuchter, A.F., Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depression and Anxiety 30:7 (2013), 624–630, 10.1002/da.22045.
30. Katsanis, S.H., Javitt, G., Hudson, K., Public health: A case study of personalized medicine. Science 320:5872 (2008), 53–54, 10.1126/science.1156604.
31. Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J., Johnson, B.T., Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2), 2008, e45, 10.1371/journal.pmed.0050045.
32. Kraemer, H.C., Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: A parametric approach. Statistics in Medicine 32:11 (2013), 1964–1973, 10.1002/sim.5734.
33. Kraemer, H.C., Wilson, G.T., Fairburn, C.G., Agras, W.S., Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59:10 (2002), 877–883.
34. Leichsenring, F., Rabung, S., Effectiveness of long-term psychodynamic psychotherapy: A meta-analysis. JAMA 300:13 (2008), 1551–1565, 10.1001/jama.300.13.1551.
35. Malouff, J.M., Thorsteinsson, E.B., Schutte, N.S., The efficacy of problem solving therapy in reducing mental and physical health problems: A meta-analysis. Clinical Psychology Review 27:1 (2007), 46–57, 10.1016/j.cpr.2005.12.005.
36. Marcus, D.K., O'Connell, D., Norris, A.L., Sawaqdeh, A., Is the dodo bird endangered in the 21st century? A meta-analysis of treatment comparison studies. Clinical Psychology Review 34:7 (2014), 519–530, 10.1016/j.cpr.2014.08.001.
37. Mohr, D.C., Boudewyn, A.C., Goodkin, D.E., Bostrom, A., Epstein, L., Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology 69:6 (2001), 942–949.
38. Molenaar, P.C.M., A manifesto on psychology as idiographic science: Bringing the person back into scientific psychology, this time forever. Measurement: Interdisciplinary Research and Perspectives 2:4 (2004), 201–218, 10.1207/s15366359mea0204_1.
39. Molenaar, P.C.M., Campbell, C.G., The new person-specific paradigm in psychology. Current Directions in Psychological Science 18:2 (2009), 112–117, 10.1111/j.1467-8721.2009.01619.x.
40. Moncrieff, J., Kirsch, I., Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. Contemporary Clinical Trials 43 (2015), 60–62, 10.1016/j.cct.2015.05.005.
41. National Institute for Health and Clinical Excellence, Depression in adults: Guidance and guidelines. 2009, Author, London, UK.
42. Orsini, N., Bottai, M., Higgins, J., Buchan, I., HETEROGI: Stata module to quantify heterogeneity in a meta-analysis. 2006, Stata.
43. Paul, G.L., Strategy of outcome research in psychotherapy. Journal of Consulting Psychology 31:2 (1967), 109–118.
44. Rabinoff, M., Kitchen, C.M.R., Cook, I.A., Leuchter, A.F., Evaluation of quantitative EEG by classification and regression trees to characterize responders to antidepressant and placebo treatment. Open Medical Informatics Journal 5 (2011), 1–8, 10.2174/1874431101105010001.
45. Riedel, M., Möller, H.-J., Obermeier, M., Adli, M., Bauer, M., Kronmüller, K., Seemüller, F., Clinical predictors of response and remission in inpatients with depressive syndromes. Journal of Affective Disorders 133:1-2 (2011), 137–149, 10.1016/j.jad.2011.04.007.
46. Schneider, R.L., Arch, J.J., Wolitzky-Taylor, K.B., The state of personalized treatment for anxiety disorders: A systematic review of treatment moderators. Clinical Psychology Review 38 (2015), 39–54, 10.1016/j.cpr.2015.02.004.
47. Simon, G.E., Perlis, R.H., Personalized medicine for depression: Can we match patients with treatments?. American Journal of Psychiatry 167:12 (2010), 1445–1455, 10.1176/appi.ajp.2010.09111680.
48. Sobell, M.B., Sobell, L.C., Individualized behavior therapy for alcoholics. Behavior Therapy 4:1 (1973), 49–72, 10.1016/S0005-7894(73)80074-7.
49. Tolin, D.F., Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clinical Psychology Review 30:6 (2010), 710–720, 10.1016/j.cpr.2010.05.003.
50. Topol, E.J., Lauer, M.S., The rudimentary phase of personalised medicine: Coronary risk scores. Lancet 362:9398 (2003), 1776–1777, 10.1016/S0140-6736(03)14941-0.
51. Vittengl, J.R., Clark, L.A., Dunn, T.W., Jarrett, R.B., Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy's effects. Journal of Consulting and Clinical Psychology 75:3 (2007), 475–488, 10.1037/0022-006X.75.3.475.
52. Wampold, B.E., Minami, T., Baskin, T.W., Callen Tierney, S., A meta-(re)analysis of the effects of cognitive therapy versus “other therapies” for depression. Journal of Affective Disorders 68:2-3 (2002), 159–165.